Pathologic stage following preoperative chemoradiotherapy underestimates the risk of developing distant metastasis in rectal cancer: A comparison to staging without preoperative chemoradiotherapy
Authors:
- 24 February 2016
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 113 (6) , 692-699
Abstract
Background and Objectives: There is still little evidence of a relationship between pathologic stage with or without preoperative chemoradiotherapy (CRT) in rectal cancer. The aim of this study was to investigate the prognostic implication of the preoperative‐CRT pathologic stage (ypStage) by comparing it to the pathologic stage without preoperative‐CRT (pStage).Methods: Between July 2004 and December 2012, 774 consecutive patients who received radical surgery for histologically diagnosed rectal adenocarcinoma (clinical stage I–III) were included.Results: A total of 674 surviving patients were followed‐up for a median of 43.4 months. Five‐year local recurrence (LR) ‐free survival rates were similar for each ypStage and the corresponding pStage. In contrast, 5‐year distant metastasis (DM) ‐free survival rates were poorer for each ypStage than for the corresponding pStage. The hazard ratio increased with a decrease in pathological stages (Stage I: 3.5, Stage II: 2.2, and Stage III: 1.4).Conclusions: ypStage in rectal cancer is a good prognostic factor in predicting LR and DM. Although the ypStage can stratify patients according to the risk of developing DM, the risk as determined by the ypStage could be higher than that of corresponding pStage, especially in patients showing a higher degree of downstaging. J. Surg. Oncol. 2016;113:692–699.Keywords
This publication has 23 references indexed in Scilit:
- Learning curve of laparoscopic low anterior resection in terms of local recurrenceJournal of Surgical Oncology, 2014
- Pretreatment Expression of 13 Molecular Markers as a Predictor of Tumor Responses After Neoadjuvant Chemoradiation in Rectal CancerAnnals of Surgery, 2014
- Oncologic outcomes of pathologic stage I lower rectal cancer with or without preoperative chemoradiotherapy: Are they comparable?Surgery, 2011
- Effects of Postoperative Adjuvant Radiotherapy on Recurrence and Survival in Stage III Rectal CancerJournal of Gastrointestinal Surgery, 2011
- Pathologic stage is most prognostic of disease‐free survival in locally advanced rectal cancer patients after preoperative chemoradiationCancer, 2008
- Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203Journal of Clinical Oncology, 2006
- Chemotherapy with Preoperative Radiotherapy in Rectal CancerNew England Journal of Medicine, 2006
- Clinical and Pathologic Predictors of Locoregional Recurrence, Distant Metastasis, and Overall Survival in Patients Treated With Chemoradiation and Mesorectal Excision for Rectal CancerAmerican Journal of Clinical Oncology, 2006
- Preoperative versus Postoperative Chemoradiotherapy for Rectal CancerNew England Journal of Medicine, 2004
- MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORSStatistics in Medicine, 1996